Paul Beswick

1.7k total citations
38 papers, 1.0k citations indexed

About

Paul Beswick is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, Paul Beswick has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Organic Chemistry and 9 papers in Immunology. Recurrent topics in Paul Beswick's work include Antimicrobial Peptides and Activities (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Synthesis and Biological Evaluation (5 papers). Paul Beswick is often cited by papers focused on Antimicrobial Peptides and Activities (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Synthesis and Biological Evaluation (5 papers). Paul Beswick collaborates with scholars based in United Kingdom, United States and Switzerland. Paul Beswick's co-authors include Simon E. Ward, Michael C. Willis, David A. Widdowson, Robert J. Gleave, D. I. C. SCOPES, Jason Brown, Oliver N. F. King, Ganesha Rai, J. W. CLITHEROW and Robert J. Klose and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Cancer Research.

In The Last Decade

Paul Beswick

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Beswick United Kingdom	20	471	443	126	89	84	38	1.0k
Andrew J. Peat United States	20	683 1.5×	705 1.6×	53 0.4×	131 1.5×	56 0.7×	36	1.5k
Ethel C. Garnier‐Amblard United States	12	356 0.8×	552 1.2×	69 0.5×	154 1.7×	59 0.7×	13	1.2k
Janina Baraniak Poland	19	332 0.7×	979 2.2×	44 0.3×	157 1.8×	36 0.4×	56	1.4k
Adrianus M. C. H. van den Nieuwendijk Netherlands	19	738 1.6×	848 1.9×	37 0.3×	75 0.8×	44 0.5×	42	1.4k
Neng‐Yang Shih United States	20	583 1.2×	564 1.3×	80 0.6×	96 1.1×	303 3.6×	57	1.3k
Eric E. Boros United States	16	283 0.6×	473 1.1×	80 0.6×	35 0.4×	49 0.6×	36	840
Robert Aslanian United States	23	756 1.6×	623 1.4×	74 0.6×	59 0.7×	243 2.9×	83	1.4k
Fabrizio Bordi Italy	15	335 0.7×	409 0.9×	33 0.3×	62 0.7×	184 2.2×	53	750
Xiaohu Deng United States	15	863 1.8×	256 0.6×	72 0.6×	46 0.5×	24 0.3×	47	1.1k
Edward R. Bacon United States	18	453 1.0×	321 0.7×	56 0.4×	38 0.4×	120 1.4×	57	988

Countries citing papers authored by Paul Beswick

Since Specialization

Citations

This map shows the geographic impact of Paul Beswick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Beswick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Beswick more than expected).

Fields of papers citing papers by Paul Beswick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Beswick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Beswick. The network helps show where Paul Beswick may publish in the future.

Co-authorship network of co-authors of Paul Beswick

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Beswick. A scholar is included among the top collaborators of Paul Beswick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Beswick. Paul Beswick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stanway, Steven J., Katerine Van Rietschoten, Dom Bellini, et al.. (2025). Discovery and chemical optimisation of a potent, Bi-cyclic antimicrobial inhibitor of Escherichia coli PBP3. Communications Biology. 8(1). 819–819. 1 indexed citations

Stanway, Steven J., et al.. (2024). Investigating Penetration and Antimicrobial Activity of Vector-Bicycle Conjugates. ACS Infectious Diseases. 10(7). 2381–2389. 1 indexed citations

Walsh, Stephen J., Johanna Lahdenranta, Philip Huxley, et al.. (2024). Abstract 5807: Bicycle Toxin Conjugates®for the treatment of solid tumors. Cancer Research. 84(6_Supplement). 5807–5807.

Stanway, Steven J., Yuliya Demydchuk, G.A. Bezerra, et al.. (2023). Structure-Guided Chemical Optimization of Bicyclic Peptide (Bicycle) Inhibitors of Angiotensin-Converting Enzyme 2. Journal of Medicinal Chemistry. 66(14). 9881–9893. 3 indexed citations

Rigby, Michael, Gavin Bennett, Liuhong Chen, et al.. (2022). BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors. Molecular Cancer Therapeutics. 21(12). 1747–1756. 41 indexed citations

Mudd, Gemma, Liuhong Chen, Katerine Van Rietschoten, et al.. (2022). Discovery of BT8009: A Nectin-4 Targeting Bicycle Toxin Conjugate for the Treatment of Cancer. Journal of Medicinal Chemistry. 65(21). 14337–14347. 58 indexed citations

Beswick, Paul, et al.. (2019). A challenge finding P2X1 and P2X4 ligands. Neuropharmacology. 157. 107674–107674. 5 indexed citations

Rigby, Mike, Paul Beswick, Gemma Mudd, et al.. (2019). Abstract 4479: BT8009: A bicyclic peptide toxin conjugate targeting Nectin-4 (PVRL4) displays efficacy in preclinical tumor models. Cancer Research. 79(13_Supplement). 4479–4479. 6 indexed citations

Askwith, Trevor, John Atack, Paul Beswick, et al.. (2017). African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase. European Journal of Medicinal Chemistry. 141. 676–689. 15 indexed citations

10.

Beswick, Paul, Lueacha Tabtimmai, Irina Chuckowree, et al.. (2016). Evaluation of the anti-malarial activity and cytotoxicity of 2,4-diamino-pyrimidine-based kinase inhibitors. European Journal of Medicinal Chemistry. 124. 896–905. 24 indexed citations

11.

Young, Robert J., W. Alderton, Paul Beswick, et al.. (2011). Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor. Bioorganic & Medicinal Chemistry Letters. 21(10). 3037–3040. 2 indexed citations

12.

Stevens, Alexander J., Anton D. Michel, Daryl S. Walter, et al.. (2010). Synthesis and structure–activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor. Bioorganic & Medicinal Chemistry Letters. 20(10). 3161–3164. 21 indexed citations

13.

Beswick, Paul, Andy Billinton, David K. Dean, et al.. (2010). Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X7 receptor. Bioorganic & Medicinal Chemistry Letters. 20(22). 6370–6374. 25 indexed citations

14.

Gleave, Robert J., Daryl S. Walter, Paul Beswick, et al.. (2010). Synthesis and biological activity of a series of tetrasubstituted-imidazoles as P2X7 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(16). 4951–4954. 25 indexed citations

15.

King, Oliver N. F., Masaaki Sakurai, Akane Kawamura, et al.. (2010). Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors. PLoS ONE. 5(11). e15535–e15535. 173 indexed citations

16.

Beswick, Paul, Andy Billinton, David K. Dean, et al.. (2010). Structure–activity relationships and in vivo activity of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor. Bioorganic & Medicinal Chemistry Letters. 20(15). 4653–4656. 23 indexed citations

17.

Gleave, Robert J., Paul Beswick, Andrew J. Brown, et al.. (2009). 2-Amino-5-aryl-pyridines as selective CB2 agonists: Synthesis and investigation of structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 19(23). 6578–6581. 9 indexed citations

18.

Bingham, Sharon, Paul Beswick, David Blum, Norman M. Gray, & Iain P. Chessell. (2006). The role of the cylooxygenase pathway in nociception and pain. Seminars in Cell and Developmental Biology. 17(5). 544–554. 34 indexed citations

19.

Willis, Michael C., et al.. (2003). Chelation‐Controlled Intermolecular Hydroacylation: Direct Addition of Alkyl Aldehydes to Functionalized Alkenes. Angewandte Chemie International Edition. 43(3). 340–343. 114 indexed citations

20.

Beswick, Paul, et al.. (1984). Synthetic applications of lithiated tricarbonyl-η⁶-arenechromium(0) complexes: copper and palladium catalysed substitutions. Journal of the Chemical Society Chemical Communications. 46–48. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact